Search League Tables

Thursday, 17 May 2012

Food for thought

Del Monte settlement quantifies cost of conflicts

Wall Street just got a bill for its conflicts of interest problem – and Barclays is picking up the tab. The UK bank will surrender a big slug of the fees it earned in the $5.3 billion buyout of Del Monte as part of a legal settlement with the food company’s shareholders. M&A practitioners seem to have read the writing on the wall after a Delaware judge earlier condemned the practice of advising a seller while also financing the buyer. But when banks get spanked on the bottom line, the message resonates louder and clearer.

The Del Monte case stunned the dealmaking world earlier this year. Barclays hadn’t even been named as an original defendant. That didn’t deter a Delaware court from dragging it into the case and saying the bank “secretly and selfishly manipulated” the Del Monte auction to line its own pockets with additional fees. The accusations got the attention of bankers everywhere, who until then hadn’t much seen the problem with so-called “staple financing,” or lending money to a private equity firm so it could acquire a company the advisers were simultaneously helping to sell.

Banks won’t necessarily concede any change of heart. But the evidence so far speaks for itself. While the volume of leveraged buyouts has shrunk considerably, it’s nevertheless hard to find an example since February, when the judge first ruled, of any sizable deal where a bank has engaged in the practice. This week’s $3.9 billion buyout of Pharmaceutical Product Development, for example, included four financing banks for Carlyle and Hellman & Friedman, none of which was a named adviser on the deal.

The now quantifiable cost of such conflicts of interest should help drive the point home. Barclays, though it isn’t admitting any wrongdoing, will kick in nearly $24 million to the $89 million deal with Del Monte shareholders. And the Wall Street Journal is reporting that Del Monte will withhold another $21 million of fees from Barclays to help cover its portion of the settlement. It isn’t easy to alter the methods of bankers. But removing the financial incentive works almost every time.

Context News

Del Monte and Barclays Capital said on Oct. 6 they had agreed to pay $89.4 million to Del Monte shareholders to settle a lawsuit that alleged conflicts of interest in last year’s $5.3 billion buyout of the company by Kohlberg Kravis Roberts, Vestar Capital and Centerview Partners. The case centered on Barclays advising Del Monte while also providing financing to the buyers

Del Monte, Barclays and other defendants do not admit any wrongdoing as part of the settlement.

Del Monte will pay $65.7 million and Barclays $23.7 million. The settlement is subject to approval by the Delaware court.

“We are pleased that the parties have agreed to settle the litigation to avoid the expense, distraction and uncertainty of litigation,” Barclays said.

Del Monte declined to comment.

(Launches in a new window)